{"id":3021,"date":"2016-07-22T17:11:04","date_gmt":"2016-07-22T17:11:04","guid":{"rendered":"http:\/\/www.medicalmarijuanainc.com\/?p=16568"},"modified":"2016-07-22T17:11:04","modified_gmt":"2016-07-22T17:11:04","slug":"kannalife-sciences-featured-forbes","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2016\/07\/22\/kannalife-sciences-featured-forbes\/","title":{"rendered":"Kannalife Sciences Featured in Forbes’ Discussion of NFL and CTE"},"content":{"rendered":"
Medical Marijuana, Inc. CEO Stuart Titus was featured by Forbes this week, explaining Kannalife\u2122 Sciences role in developing a pharmaceutical treatment for Chronic Traumatic Encephalopathy (CTE). CTE is a degenerative brain disorder caused by repeated brain trauma, which has shown to be pervasive amongst NFL players in recent years.<\/p>\n
Read the article below, or at its original source here<\/a>.
\n